Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.

The Biden administration has added popular weight loss and diabetes drugs, including Ozempic and Wegovy, to Medicare’s list ...

Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Medicare announces 15 new drugs chosen for price negotiations, including popular weight loss drug Ozempic - Any negotiated ...